Figure 3 | Cancer Gene Therapy

Figure 3

From: Carrier cell-based delivery of replication-competent HSV-1 mutants enhances antitumor effect for ovarian cancer

Figure 3

HF10 and Hh101 replication in mesothelial cells (MCs), human omentum mesothelial cells (HOmMCs) and SKOV3 cells. SKOV3 cells (a, black line) and MCs (b, red line) were infected with HF10 at multiplicities of infection (MOI) 3. SKOV3 cells (c, black line) and HOmMCs (d, red line) were infected with Hh101 at MOI 3. Representative cytopathogenic effects (CPE) are shown as time series. Cells were harvested and virus titer was determined by plaque assay. The red dotted line shows virus titers in MCs infected with Hh101 at MOI 0.03 (e, f). The values represent the mean of samples tested in triplicate. PFU, plaque-forming unit.

Back to article page